Katinko External Analgesic Oil CAMPHOR (SYNTHETIC), MENTHOL, METHYL SALICYLATE 50 mg/mL; 160 mg/mL; 300 mg/mL Oil — NDC 52241-301-02 (Billing 52241-0301-02)
This is a package of Katinko External Analgesic Oil CAMPHOR (SYNTHETIC), MENTHOL, METHYL SALICYLATE 50 mg/mL; 160 mg/mL; 300 mg/mL Oil from Greenstone Pharmaceutical Inc., marketed since Jun 2023 and currently FDA-listed.
NDC database record
One package, one record: these facts belong to NDC 52241-301-02 alone.
- Record
- FDA NDC Directory package listing · Human OTC drug
- Code segments
- 52241 labeler · 301 product · 02 package
- Package marketed since
- Jun 1, 2023
- Sample package
- No — commercial package
- Listing certified through
- Dec 31, 2026
- Barcode (UPC-A, from the NDC)
- 3 5224130102 7
- FDA record last changed
- Jul 24, 2026
Identity & classification
Regulatory identifiers FDA, NLM and CMS codes for this package
- RxCUI (RxNorm): 2637881
Where does this data come from?
- FDA openFDA NDC Directory · synced Oct 1, 2026
- FDA label on DailyMed · label index refreshed Oct 6, 2026
- RxNorm (NLM RxNav) · catalog refreshed Oct 1, 2026
- Medi-Span GPI (licensed)
- First Databank (licensed) · refreshed Oct 1, 2026
Clinical
Katinko External Analgesic Oil is a topical oil product marketed as an over-the-counter monograph drug. It contains three active ingredients: synthetic camphor, menthol, and methyl salicylate, which are commonly combined in external pain-relief products. These ingredients are typically used to produce a warming or cooling sensation on the skin and are found in products intended for temporary relief of minor muscle and joint discomfort when applied to the affected area.
Patient education
Supplement & herbal interactions
Where does this data come from?
- MedlinePlus (NLM) · refreshed Oct 1, 2026
- FDA label on DailyMed · label index refreshed Oct 6, 2026
Ask a licensed pharmacist directly — free, answered by our team.
Pricing
A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.
| Price system | Per each | Per package |
|---|---|---|
| Retail pharmacies payNADAC · weekly | Not in the retail survey — common for institutional, discontinued, or low-volume packs. | |
| Medicaid paysCMS SDUD · 12 mo | No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data. | |
| Medicare drug plans payPart D · quarterly | No Part D plan price is available for this NDC in our data. | |
Where does this data come from?
- CMS NADAC weekly file
- CMS ASP pricing files · refreshed Sep 20, 2026
- CMS Medicaid State Drug Utilization Data · refreshed Oct 6, 2026
- CMS Part D plan pricing files · refreshed Sep 24, 2026
- VA National Acquisition Center price file
Packaging — all sizes for this product
| Package NDC | Description | Marketing start | Marketing end | Status |
|---|---|---|---|---|
| 52241-0301-01 52241-301-01 Main listing | 1 BOTTLE in 1 CARTON / 10 mL in 1 BOTTLE | 2023-06-01 | — | Active |
| 52241-0301-02 You're viewing this | 1 BOTTLE, GLASS in 1 CARTON / 35 mL in 1 BOTTLE, GLASS | 2023-06-01 | — | Active |
Pack size FAQ
What quantity is in this package?
What NDC number is used to bill for this package of Katinko External Analgesic Oil CAMPHOR (SYNTHETIC), MENTHOL, METHYL SALICYLATE 50 mg/mL; 160 mg/mL; 300 mg/mL Oil?
Therapeutic equivalents
| Product | Labeler | Pack | NADAC/unit | TE | Status | Price vs. this |
|---|---|---|---|---|---|---|
| Katinko External Analgesic Oil 50 mg/mL; 160 mg/mL; 300 mg/mLthis 52241-0301-02 | Greenstone | 1 bottle | — | — | FDA listed | — |
Where does this data come from?
- FDA openFDA NDC Directory · synced Oct 1, 2026
- FDA Orange Book · refreshed Oct 3, 2026
- CMS NADAC weekly file
Availability & generic status
We did not find an FDA-approved generic match for this exact strength, form and route.
Where does this data come from?
- FDA Orange Book · refreshed Oct 3, 2026
Inactive Ingredients / Excipients
Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.
💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.
-
UNII T5L8T28FGP
Mineral oil is a clear, odorless liquid derived from crude oil. It acts as a lubricant and emollient in medications, helping pills slide smoothly during manufacturing and aiding moisture retention in topical products.
1 inactive ingredient listed in the exact product block matched to this NDC.
Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.
Where does this data come from?
ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.- FDA label on DailyMed · label index refreshed Oct 6, 2026
- FDA openFDA NDC Directory · synced Oct 1, 2026
Inactive ingredient FAQ
Are inactive ingredients the same for every manufacturer?
Why might an inactive ingredient be missing?
Can inactive ingredients matter?
Manufacturer & labeler
More NDCs from Greenstone Pharmaceutical Inc. labeler code 52241
Where does this data come from?
- FDA openFDA NDC Directory · synced Oct 1, 2026
- Drugs@FDA
FDA label — Drug Facts FDA SPL
🎯 Indications and Usage ▾
Use For the temporary relief of minor aches and pains of muscles and joints.
⏱️ Dosage and Administration ▾
Directions Adults and children 3 years of age and older. Apply to affected area not more than 3 to 4 times daily Children under 3 years of age: Consult a doctor.
⚠️ Warnings ▾
Warnings For external use only When using this product avoid contact with eyes or mucous membranes do not apply to wounds or damaged skin do not bandage tightly do not use otherwise than as directed Stop use and ask a doctor if condition worsens, or if symptoms persist for more than 7 days or clear up and occur again within a few days excessive irritation of the skin develops Keep out of reach of children If swallowed, get medical help or contact a Poison Control Center right away. to avoid accidental poisoning.
🧪 Active Ingredient ▾
Active ingredients Camphor 5% Menthol 16% Methyl salicylate 30% Purpose External analgesic
🧪 Inactive Ingredients ▾
Inactive ingredients Light Mineral Oil
🎯 Purpose ▾
Purpose External analgesic
📄 When Using This Product ▾
When using this product avoid contact with eyes or mucous membranes do not apply to wounds or damaged skin do not bandage tightly do not use otherwise than as directed
📄 Stop Use and Ask a Doctor If ▾
Stop use and ask a doctor if condition worsens, or if symptoms persist for more than 7 days or clear up and occur again within a few days excessive irritation of the skin develops
📄 Keep Out of Reach of Children ▾
Keep out of reach of children If swallowed, get medical help or contact a Poison Control Center right away. to avoid accidental poisoning.
📄 Package Label / Principal Display Panel ▾
Package Labeling:52241-301-01 Outer Package Inner Package
Package Labeling:52241-301-02 Outer Package2 Inner Package2
About this NDC listing & data coverage
What data is (and isn’t) available for this NDC — tap to expand
| NDC identity (package / product / labeler codes) | ✓ Available |
| Labeler | ✓ Available |
| Product & package description | ✓ Available |
| Marketing category & status | ✓ Available |
| Active ingredient / dosage form / route | ✓ Available |
| FDA label (SPL via DailyMed) | ✓ Available |
| Package photos | ✓ Available |
| Inactive ingredients (structured) | ✓ Available |
| NADAC pharmacy acquisition price (CMS) | — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey. |
| Orange Book / therapeutic-equivalence data | — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope. |
| HCPCS J-code billing crosswalk | — Not published for this NDC Most self-administered / retail products have no J-code — that is normal. |
| Medicaid utilization (CMS SDUD) | — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold. |